Continuing Education
Cost Implications for Novel Therapies and Strategies in the Treatment of NSCLC: Perspectives and Clinical Updates from ASCO 2011Available for credit: 08/19/2011 - 08/19/2012 |
The Evolving Role of Outcomes and End Points in Evaluating Therapy for Hematologic Malignancies: Value-Driven Benefit Design and Utilization Management StrategiesAvailable for credit: 07/15/2011 - 07/15/2012 |
Improving the Prevention and Treatment of Venous Thromboembolism in Cancer: The Strategic Role of the Health-System PharmacistAvailable for credit: 04/22/2011 |
Maintenance Therapy for Non–Small-Cell Lung Cancer: A Value-Based Approach to Improve Patient Care and Outcomes, Part II of IIAvailable for credit: 11/19/2010 - 11/19/2011 |
Maintenance Therapy for Non–Small-Cell Lung Cancer: A Value-Based Approach to Improve Patient Care and Outcomes, Part I of IIAvailable for credit: 10/15/2010 - 10/15/2011 |